+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medicinal Grade Cannabis Market - Global Forecast 2026-2032- Product Image
Medicinal Grade Cannabis Market - Global Forecast 2026-2032- Product Image
Sale

Medicinal Grade Cannabis Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283260
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medicinal-Grade Cannabis: Executive Summary and Market Context

Medicinal-grade cannabis refers to cannabis-derived products manufactured and controlled for therapeutic use under applicable pharmaceutical, medical, and controlled-substance requirements. The field spans cultivation, extraction, formulation, testing, prescribing, dispensing, and patient monitoring. Its development is shaped by evidence standards, product consistency, physician confidence, reimbursement rules, and national approaches to cannabis regulation.

Regulatory, Clinical, and Supply-Chain Shifts Reshaping Medicinal Cannabis

The landscape is shifting from narrowly defined access programs toward more structured frameworks emphasizing quality systems, traceability, laboratory testing, pharmacovigilance, and appropriate clinical oversight. Regulators and healthcare systems increasingly distinguish between standardized medicinal products and non-medical cannabis, while policymakers continue to debate prescription pathways, qualifying conditions, and cultivation controls. Supply chains are also becoming more specialized, with greater attention to contaminant limits, batch consistency, import documentation, and secure distribution.

Artificial Intelligence’s Cumulative Impact on Quality and Care

Artificial intelligence can support medicinal-grade cannabis through demand and inventory planning, anomaly detection in cultivation and manufacturing data, laboratory quality review, adverse-event signal detection, and patient-support tools. Its value depends on validated data, transparent models, cybersecurity, and human oversight. AI should complement rather than replace clinical judgment, regulatory review, laboratory confirmation, or informed patient consent, particularly where product variability and limited long-term evidence remain concerns.

Regional Insights Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America has generally advanced the institutionalization of medicinal cannabis through distinct federal, state, provincial, or territorial approaches, although access and product rules remain uneven. Latin America is characterized by evolving medical frameworks, varied cultivation policies, and differing enforcement practices. Europe emphasizes pharmaceutical-quality controls and national authorization pathways, with substantial differences among jurisdictions. Middle Eastern policy remains highly cautious, with access typically constrained by strict medical and controlled-substance rules. Africa shows emerging regulatory interest alongside infrastructure, affordability, and clinical-capacity challenges. Asia-Pacific combines mature medical systems with highly diverse cannabis policies, ranging from tightly restricted access to developing therapeutic programs.

Group Insights: ASEAN, BRICS, EU, G7, GCC, and NATO Policy Contexts

ASEAN members generally approach medicinal cannabis cautiously, with significant variation in eligibility, cultivation, research, and prescribing rules. BRICS economies reflect diverse regulatory models and healthcare infrastructures, making harmonization difficult. The European Union provides an important reference environment for pharmaceutical manufacturing, safety, and cross-border compliance, although national cannabis rules remain decisive. G7 members combine advanced research and healthcare systems with differing legal classifications and reimbursement approaches. GCC states typically maintain restrictive controlled-substance regimes, while NATO membership does not create a unified cannabis policy; relevant rules remain national and, in some cases, subnational.

Country Insights: Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the UK, and US

Australia has developed regulated medicinal access supported by prescription controls and an established research framework. Brazil permits defined medical uses while continuing to refine regulatory and judicial boundaries. Canada operates a mature federally regulated system with provincial and territorial differences in care delivery. China maintains a highly controlled approach, with activity concentrated in regulated industrial, research, or medical contexts. France, Germany, Italy, Spain, and the United Kingdom apply distinct European models centered on medical authorization, prescribing, and product standards. India’s rules vary by product category and jurisdiction, with research and traditional-use considerations influencing policy. Japan and South Korea maintain tightly controlled medical pathways. Mexico continues to develop its framework. Russia applies restrictive controls. The United States combines federal restrictions with state-level medical programs, creating substantial legal and operational complexity.

Practical Priorities for Leaders in Medicinal-Grade Cannabis

Industry leaders should prioritize compliance-by-design, including validated cultivation and manufacturing processes, independent laboratory testing, documented chain of custody, and robust recall procedures. Clinical strategy should focus on well-defined indications, meaningful outcomes, transparent evidence communication, and physician education. Organizations should map each jurisdiction’s licensing, import, prescribing, labeling, advertising, and pharmacovigilance requirements before entering it. Investment in secure data systems, interoperable records, workforce training, and responsible AI governance can improve reliability without weakening clinical accountability. Partnerships with healthcare providers and patient groups should be structured around safety, access, and informed use.

Research Methodology for a Regulatory and Evidence-Based Assessment

This executive summary uses a structured qualitative review framework focused on medicinal-grade cannabis as a regulated therapeutic category. Analysis should triangulate primary legislation, regulator guidance, official health-system information, recognized clinical literature, pharmacopoeial or quality standards, and publicly documented supply-chain requirements. Findings are organized by regulatory environment, clinical evidence, manufacturing quality, technology adoption, and geography. Because rules and evidence evolve, conclusions should be rechecked against current national authorities and product-specific requirements before commercial, clinical, or investment decisions are made.

Conclusion: Building Trust Through Quality, Evidence, and Responsible Access

Medicinal-grade cannabis is developing at the intersection of controlled-substance regulation, pharmaceutical manufacturing, clinical research, and patient-centered care. Progress will depend less on broad availability alone than on consistent product quality, credible evidence, responsible prescribing, secure distribution, and transparent oversight. Organizations that align scientific rigor with jurisdiction-specific compliance and measurable patient outcomes will be better positioned to support safe, durable development across diverse regional and national environments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medicinal Grade Cannabis Market, by Product Form
7.1. Introduction
7.2. Dried Cannabis Flower
7.3. Cannabis Tinctures
7.4. Edible Medicinal Cannabis Products
7.5. Cannabis Extracts & Oils
8. Medicinal Grade Cannabis Market, by Active Compound
8.1. Introduction
8.2. THC-Dominant Cannabis Products
8.3. CBD-Dominant Cannabis Products
8.4. Balanced THC/CBD Products
9. Medicinal Grade Cannabis Market, by Route of Administration
9.1. Introduction
9.2. Oral Consumption Products
9.3. Inhalation Products
9.4. Sublingual Administration Products
9.5. Topical Cannabis Products
10. Medicinal Grade Cannabis Market, by Medical Application
10.1. Introduction
10.2. Mental Health & Anxiety Treatment
10.3. Pain Management
10.4. Neurological Disorders
10.5. Oncology Supportive Care
11. Medicinal Grade Cannabis Market, by End User
11.1. Introduction
11.2. Medical Cannabis Dispensaries
11.3. Hospitals & Clinics
12. Medicinal Grade Cannabis Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Medicinal Grade Cannabis Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Medicinal Grade Cannabis Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Aurora Cannabis Inc.
16.2. BOL Pharma
16.3. Cannabis Sativa, Inc.
16.4. Canntab Therapeutics Limited
16.5. Canopy Growth Corporation
16.6. Cresco Labs Inc.
16.7. Cronos Group Inc.
16.8. Curaleaf Holdings Inc.
16.9. GB Sciences Inc.
16.10. Green Relief Inc.
16.11. GW Pharma plc
16.12. HEXO Corp
16.13. Medical Marijuana, Inc.
16.14. MediPharm Labs Corp.
16.15. MGC Pharmaceuticals Limited
16.16. Organigram Holdings Inc.
16.17. Tikun Olam Ltd.
16.18. Tilray Brands, Inc.
16.19. United Cannabis Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medicinal Grade Cannabis Market, Years Considered for the Study
FIGURE 2. Global Medicinal Grade Cannabis Market, Research Design
FIGURE 3. Global Medicinal Grade Cannabis Market, Research Framework
FIGURE 4. Global Medicinal Grade Cannabis Market, Data Triangulation
FIGURE 5. Global Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medicinal Grade Cannabis Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 7. Global Medicinal Grade Cannabis Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medicinal Grade Cannabis Market Size, by Active Compound, 2025 vs 2032 (%)
FIGURE 9. Global Medicinal Grade Cannabis Market Size, by Active Compound, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medicinal Grade Cannabis Market Size, by Route of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Medicinal Grade Cannabis Market Size, by Route of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medicinal Grade Cannabis Market Size, by Medical Application, 2025 vs 2032 (%)
FIGURE 13. Global Medicinal Grade Cannabis Market Size, by Medical Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medicinal Grade Cannabis Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Medicinal Grade Cannabis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medicinal Grade Cannabis Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Medicinal Grade Cannabis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Medicinal Grade Cannabis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medicinal Grade Cannabis Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Medicinal Grade Cannabis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Medicinal Grade Cannabis Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medicinal Grade Cannabis Market Segmentation & Coverage
TABLE 2. Global Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 4. Global Dried Cannabis Flower Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Dried Cannabis Flower Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Dried Cannabis Flower Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cannabis Tinctures Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cannabis Tinctures Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cannabis Tinctures Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Edible Medicinal Cannabis Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Edible Medicinal Cannabis Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Edible Medicinal Cannabis Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Cannabis Extracts & Oils Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Cannabis Extracts & Oils Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Cannabis Extracts & Oils Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 17. Global THC-Dominant Cannabis Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global THC-Dominant Cannabis Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global THC-Dominant Cannabis Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global CBD-Dominant Cannabis Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global CBD-Dominant Cannabis Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global CBD-Dominant Cannabis Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Balanced THC/CBD Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Balanced THC/CBD Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Balanced THC/CBD Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 27. Global Oral Consumption Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Oral Consumption Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Oral Consumption Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Inhalation Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Inhalation Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Inhalation Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Sublingual Administration Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Sublingual Administration Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Sublingual Administration Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Topical Cannabis Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Topical Cannabis Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Topical Cannabis Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 40. Global Mental Health & Anxiety Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Mental Health & Anxiety Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Mental Health & Anxiety Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Pain Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Pain Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Pain Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Neurological Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Neurological Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Neurological Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Oncology Supportive Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Oncology Supportive Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Oncology Supportive Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Global Medical Cannabis Dispensaries Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Medical Cannabis Dispensaries Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Medical Cannabis Dispensaries Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Medicinal Grade Cannabis Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Medicinal Grade Cannabis Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 66. North America Medicinal Grade Cannabis Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. North America Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 68. North America Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 69. North America Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 70. North America Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 71. North America Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. Latin America Medicinal Grade Cannabis Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Latin America Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 74. Latin America Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 75. Latin America Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 76. Latin America Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 77. Latin America Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Europe Medicinal Grade Cannabis Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Europe Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 80. Europe Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 81. Europe Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 82. Europe Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 83. Europe Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Middle East Medicinal Grade Cannabis Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Middle East Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 86. Middle East Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 87. Middle East Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 88. Middle East Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 89. Middle East Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Africa Medicinal Grade Cannabis Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Africa Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 92. Africa Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 93. Africa Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 94. Africa Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 95. Africa Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Global Medicinal Grade Cannabis Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. ASEAN Medicinal Grade Cannabis Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. ASEAN Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 99. ASEAN Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 100. ASEAN Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 101. ASEAN Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 102. ASEAN Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. GCC Medicinal Grade Cannabis Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. GCC Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 105. GCC Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 106. GCC Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 107. GCC Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 108. GCC Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. European Union Medicinal Grade Cannabis Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. European Union Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 111. European Union Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 112. European Union Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 113. European Union Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 114. European Union Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. BRICS Medicinal Grade Cannabis Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. BRICS Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 117. BRICS Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 118. BRICS Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 119. BRICS Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 120. BRICS Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. G7 Medicinal Grade Cannabis Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. G7 Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 123. G7 Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 124. G7 Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 125. G7 Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 126. G7 Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. NATO Medicinal Grade Cannabis Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. NATO Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 129. NATO Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 130. NATO Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 131. NATO Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 132. NATO Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Global Medicinal Grade Cannabis Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. United States Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 135. United States Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 136. United States Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 137. United States Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 138. United States Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 139. United States Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Canada Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 141. Canada Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 142. Canada Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 143. Canada Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 144. Canada Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 145. Canada Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Mexico Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 147. Mexico Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 148. Mexico Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 149. Mexico Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 150. Mexico Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 151. Mexico Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Brazil Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 153. Brazil Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 154. Brazil Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 155. Brazil Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 156. Brazil Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 157. Brazil Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. United Kingdom Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 159. United Kingdom Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 160. United Kingdom Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 161. United Kingdom Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 162. United Kingdom Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 163. United Kingdom Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Germany Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 165. Germany Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 166. Germany Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 167. Germany Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 168. Germany Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 169. Germany Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. France Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 171. France Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 172. France Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 173. France Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 174. France Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 175. France Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Russia Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 177. Russia Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 178. Russia Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 179. Russia Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 180. Russia Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 181. Russia Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Italy Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 183. Italy Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 184. Italy Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 185. Italy Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 186. Italy Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 187. Italy Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Spain Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 189. Spain Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 190. Spain Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 191. Spain Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 192. Spain Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 193. Spain Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. China Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 195. China Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 196. China Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 197. China Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 198. China Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 199. China Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. India Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 201. India Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 202. India Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 203. India Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 204. India Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 205. India Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Japan Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 207. Japan Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 208. Japan Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 209. Japan Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 210. Japan Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 211. Japan Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Australia Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 213. Australia Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 214. Australia Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 215. Australia Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 216. Australia Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 217. Australia Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. South Korea Medicinal Grade Cannabis Market Size, 2017-2032 (USD Million)
TABLE 219. South Korea Medicinal Grade Cannabis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 220. South Korea Medicinal Grade Cannabis Market Size, by Active Compound, 2017-2032 (USD Million)
TABLE 221. South Korea Medicinal Grade Cannabis Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 222. South Korea Medicinal Grade Cannabis Market Size, by Medical Application, 2017-2032 (USD Million)
TABLE 223. South Korea Medicinal Grade Cannabis Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Global Medicinal Grade Cannabis Market Share, by Key Player, 2025
TABLE 225. Global Medicinal Grade Cannabis Market, Key Experts

Companies Mentioned

  • Aurora Cannabis Inc.
  • BOL Pharma
  • Cannabis Sativa, Inc.
  • Canntab Therapeutics Limited
  • Canopy Growth Corporation
  • Cresco Labs Inc.
  • Cronos Group Inc.
  • Curaleaf Holdings Inc.
  • GB Sciences Inc.
  • Green Relief Inc.
  • GW Pharma plc
  • HEXO Corp
  • Medical Marijuana, Inc.
  • MediPharm Labs Corp.
  • MGC Pharmaceuticals Limited
  • Organigram Holdings Inc.
  • Tikun Olam Ltd.
  • Tilray Brands, Inc.
  • United Cannabis Corporation

Related Topics

Related Reports

Cannabis Pharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Cannabis Pharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Medical Cannabis Market Report by Species, Derivatives, Application, End-Use, Route of Administration, and Region 2026-2034 - Product Image

Medical Cannabis Market Report by Species, Derivatives, Application, End-Use, Route of Administration, and Region 2026-2034

  • Report
  • 150 Pages
  • Global
From
Vertical Farming for Medicinal Cannabis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Vertical Farming for Medicinal Cannabis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 210 Pages
  • Global
From
Cannabis Market - Strategic Insights and Forecasts (2026-2031) - Product Image

Cannabis Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • 142 Pages
  • Global
From
Cannabis Market by Compound Type, Product Type, Application, Source, and Region - Global Forecast to 2030 - Product Image

Cannabis Market by Compound Type, Product Type, Application, Source, and Region - Global Forecast to 2030

  • Report
  • 325 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.